Literature DB >> 1807356

The crystal structures of recombinant glycosylated human renin alone and in complex with a transition state analog inhibitor.

J Rahuel1, J P Priestle, M G Grütter.   

Abstract

Recombinant human glycosylated renin has been crystallized in complex with CGP 38'560, a transition state analog inhibitor (IC50 = 2 x 10(-9) M), in a tetragonal crystal form. The structure has been determined to a resolution of 2.4 A and refined to a crystallographic Rfactor of 17.6%. It reveals the conformation of the inhibitor as well as its interactions with the enzyme active site. The active site is a deep cleft between the N- and the C-terminal domains to which the inhibitor binds in an extended conformation filling the S4 to S2' pockets. The structure of the complex is compared with that of the related uninhibited enzyme pepsin. Significant changes in the relative orientation of the N- and C-terminal domains are observed. In the inhibited renin structure the C-terminal loop segments forming the active site are closer to those from the N-terminal domain than in the related "open" pepsin structure. In addition, the structure of uninhibited glycosylated renin has been determined at 2.8 A resolution from a cubic crystal form with two renin molecules in the asymmetric unit. The two independent renin molecules show different conformations with respect to the relative orientation of their N- and C-terminal domains; one molecule is found in the "closed inhibited" conformation, the other in the "open uninhibited" conformation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1807356     DOI: 10.1016/1047-8477(91)90048-2

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  13 in total

1.  Analysis of crystal structures of aspartic proteinases: on the role of amino acid residues adjacent to the catalytic site of pepsin-like enzymes.

Authors:  N S Andreeva; L D Rumsh
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

2.  Towards the automatic design of synthetically accessible protein ligands: peptides, amides and peptidomimetics.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1996-08       Impact factor: 3.686

3.  Deglycosylation of proteins for crystallization using recombinant fusion protein glycosidases.

Authors:  F Grueninger-Leitch; A D'Arcy; B D'Arcy; C Chène
Journal:  Protein Sci       Date:  1996-12       Impact factor: 6.725

4.  Dynamic and Electrostatic Effects on the Reaction Catalyzed by HIV-1 Protease.

Authors:  Agnieszka Krzemińska; Vicent Moliner; Katarzyna Świderek
Journal:  J Am Chem Soc       Date:  2016-12-09       Impact factor: 15.419

5.  The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins.

Authors:  Dima Kozakov; Laurie E Grove; David R Hall; Tanggis Bohnuud; Scott E Mottarella; Lingqi Luo; Bing Xia; Dmitri Beglov; Sandor Vajda
Journal:  Nat Protoc       Date:  2015-04-09       Impact factor: 13.491

Review 6.  Sequence, Structural Analysis and Metrics to Define the Unique Dynamic Features of the Flap Regions Among Aspartic Proteases.

Authors:  Lara McGillewie; Muthusamy Ramesh; Mahmoud E Soliman
Journal:  Protein J       Date:  2017-10       Impact factor: 2.371

7.  The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1994-06       Impact factor: 3.686

8.  Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: implications for the design of antifungal agents.

Authors:  C Abad-Zapatero; R Goldman; S W Muchmore; C Hutchins; K Stewart; J Navaza; C D Payne; T L Ray
Journal:  Protein Sci       Date:  1996-04       Impact factor: 6.725

Review 9.  Protein crystallography and drug discovery: recollections of knowledge exchange between academia and industry.

Authors:  Tom L Blundell
Journal:  IUCrJ       Date:  2017-06-29       Impact factor: 4.769

Review 10.  Genomes, structural biology and drug discovery: combating the impacts of mutations in genetic disease and antibiotic resistance.

Authors:  Arun Prasad Pandurangan; David B Ascher; Sherine E Thomas; Tom L Blundell
Journal:  Biochem Soc Trans       Date:  2017-04-15       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.